Cetuximab trials for Metastatic Colorectal Cancer

All Cetuximab trials · All Metastatic Colorectal Cancer trials

Phase breakdown

Recruiting trials studying Cetuximab for Metastatic Colorectal Cancer

• A Multicenter Phase 1b/2 Study of Adagrasib, Cetuximab, and Cemiplimab for Metastatic Colorectal Cancer Harboring KRAS G12C Mutations
  NCT06412198 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• A Study Evaluating the Safety and Efficacy of Targeted Therapies in Subpopulations of Patients With Metastatic Colorectal Cancer (INTRINSIC)
  NCT04929223 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 84 locations
• Combination Therapy for BRAF-V600E Metastatic CRCm
  NCT06411600 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Open-label Phase 1b Study of Ulixertinib and Cetuximab or Ulixertinib in Combination With Cetuximab and Encorafenib in Patients With Unresectable or Metastatic Colorectal Cancer Who Have Previously Received EGFR or BRAF-directed Therapy
  NCT05985954 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Study to Investigate Outcome of Individualized Treatment in Patients With Metastatic Colorectal Cancer
  NCT05725200 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location

Common questions

How many trials study Cetuximab for Metastatic Colorectal Cancer?

5 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.